Advertisement Sagent opts for Elsevier's drug information technologies - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Sagent opts for Elsevier’s drug information technologies

Specialty pharmaceutical company Sagent Pharmaceuticals has opted for Elsevier's Gold Standard's drug information technologies, ProspectoRx and Clinical Pharmacology to access current and accurate drug data and pricing.

ProspectorRx provides access to pricing data of branded drugs, generics, medical devices and supplies directly from drug companies.

Clinical Pharmacology is an electronic drug reference technology that provides current and comprehensive drug information to hospitals, retail pharmacies, health plans, PBMs, pharmaceutical manufacturers and academic institutions.

Elsevier’s Gold Standard president Marianne Messer said, "We are honored that Sagent Pharmaceuticals has selected ProspectoRx and Clinical Pharmacology to help meet their need for accurate and timely drug and pricing information."

Sagent Pharmaceuticals offers an extensive portfolio of injectable products that range from premix bags and prefilled syringes to single-dose and pharmacy bulk package vials.